经验

生物技术

About

生物技术是本所业务分支，下属于 生命科学.

为生物技术提供领先的知识产权保护

从业50多年来，飞翰曾与多家领先的生物技术公司合作，共同制定和实施成功的知识产权策略，包括为新发明申办专利、在诉讼中执行专利以及就他人提出的侵权指控或产权拥有提供辩护。飞翰曾担任礼来公司(Eli Lilly and Company)的代理人，并在涉及首个由生物技术生产并上市销售的产品—人体胰岛素—的诉讼中取得胜诉。我们提供的咨询或诉讼服务涉及多种技术，例如DNA自动测序、克隆羊多利(Dolly the sheep)、胎儿染色体异常的无创方法检测、以及抗体平台的设计。

精通法律、科学与技术

对于生物技术行业而言，有力的知识产权保护是发展的根本保障，也是继续成长的关键。作为一家由科学家和生物技术工程师组成的知识产权律所，飞翰在这发展日新月异且多学科综合的行业内始终与迅速发展的科学和不断变化的法律事务保持同步。

随着生物技术企业客户以超乎我们想象的方式取得令人兴奋的突破，我们帮助处理：

由经验丰富的审判和上诉团队在地区法院和上诉法院为高价值产品代理诉讼；
为具有重要价值的产品及技术起草和申办专利；
协助客户评估和规避众多新技术所面临密集的专利丛林；
为新技术和现有技术出具意见并提供持续的咨询服务；
在美国专利商标局复杂的专利抵触审查、专利复审程序和授权后复审程序中，担任委托人的代言人，维护委托人的利益；
就合并、收购、授权及合作进行尽职调查；
构建、起草和协商知识产权许可协议；
提供商标申办及咨询服务。

我们与处于以下科技发展前沿的客户合作：

抗体疗法
测试研发
抗癌疗法
CRISPR 技术
基因疗法
基因工程
下一代测序技术
重组生长因子
合成生物学
疫苗

该行业领域内的专业人员

经验

Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.

Representing Sarepta in defensive patent litigation involving Elevidys®, a one-time gene therapy for the treatment of a neuromuscular disease known as Duchenne muscular dystrophy (DMD) and in parallel offensive inter partes reviews (IPRs).

1:24-cv-00882, D. Del., Judge Andrews

Representing Merck in Hatch-Waxman litigation involving the HIV drugs ISENTRESS® and ISENTRESS® HD.

2:23-cv-00094, 2:23-cv-02364, D.N.J., Judges Cecchi, Padin, Wettre

Representing plaintiff Pioneer in a district court patent infringement litigation involving methods for producing doubled haploid maize plants.

1:22-cv-01280, D. Del.

Representing defendant Corteva in a Delaware state court action for breach of contract arising out of a patent cross-license agreement relating to Agrobacterium-mediated plant transformation and transgenic seeds.

N22C-07-168, Delaware Superior Court, Complex Commercial Litigation Division

Representing plaintiff Corteva Agriscience in a district court patent infringement litigation involving transgenic plants and plant cells that produce enzymes conferring herbicide resistance.

1:22-cv-01046, D. Del., Judge Williams